792 related articles for article (PubMed ID: 15514413)
1. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.
Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
Am J Psychiatry; 2004 Nov; 161(11):2108-14. PubMed ID: 15514413
[TBL] [Abstract][Full Text] [Related]
2. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission.
Zanarini MC; Frankenburg FR; Vujanovic AA; Hennen J; Reich DB; Silk KR
Acta Psychiatr Scand; 2004 Dec; 110(6):416-20. PubMed ID: 15521825
[TBL] [Abstract][Full Text] [Related]
3. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder.
Zanarini MC; Frankenburg FR; Hennen J; Silk KR
Am J Psychiatry; 2003 Feb; 160(2):274-83. PubMed ID: 12562573
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the 10-year course of borderline personality disorder.
Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
Am J Psychiatry; 2006 May; 163(5):827-32. PubMed ID: 16648323
[TBL] [Abstract][Full Text] [Related]
5. Axis I comorbidity of borderline personality disorder.
Zanarini MC; Frankenburg FR; Dubo ED; Sickel AE; Trikha A; Levin A; Reynolds V
Am J Psychiatry; 1998 Dec; 155(12):1733-9. PubMed ID: 9842784
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity of Borderline Personality Disorder: Current Status and Future Directions.
Shah R; Zanarini MC
Psychiatr Clin North Am; 2018 Dec; 41(4):583-593. PubMed ID: 30447726
[TBL] [Abstract][Full Text] [Related]
7. The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study.
Zanarini MC; Frankenburg FR; Reich DB; Silk KR; Hudson JI; McSweeney LB
Am J Psychiatry; 2007 Jun; 164(6):929-35. PubMed ID: 17541053
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of the relation of borderline personality disorder to Briquet's syndrome (hysteria), somatization disorder, antisocial personality disorder, and substance abuse disorders.
Hudziak JJ; Boffeli TJ; Kreisman JJ; Battaglia MM; Stanger C; Guze SB
Am J Psychiatry; 1996 Dec; 153(12):1598-606. PubMed ID: 8942457
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
[TBL] [Abstract][Full Text] [Related]
10. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study.
Zanarini MC; Frankenburg FR; Weingeroff JL; Reich DB; Fitzmaurice GM; Weiss RD
Addiction; 2011 Feb; 106(2):342-8. PubMed ID: 21083831
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years.
Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
J Pers Disord; 2005 Feb; 19(1):19-29. PubMed ID: 15899718
[TBL] [Abstract][Full Text] [Related]
12. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders.
Skodol AE; Oldham JM; Gallaher PE
Am J Psychiatry; 1999 May; 156(5):733-8. PubMed ID: 10327906
[TBL] [Abstract][Full Text] [Related]
13. Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substance use disorders.
Grilo CM; Martino S; Walker ML; Becker DF; Edell WS; McGlashan TH
Am J Psychiatry; 1997 Sep; 154(9):1305-7. PubMed ID: 9286195
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity of axis I and axis II disorders.
Oldham JM; Skodol AE; Kellman HD; Hyler SE; Doidge N; Rosnick L; Gallaher PE
Am J Psychiatry; 1995 Apr; 152(4):571-8. PubMed ID: 7694906
[TBL] [Abstract][Full Text] [Related]
15. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years.
Zanarini MC; Frankenburg FR; Hennen J; Silk KR
J Clin Psychiatry; 2004 Jan; 65(1):28-36. PubMed ID: 14744165
[TBL] [Abstract][Full Text] [Related]
16. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
[TBL] [Abstract][Full Text] [Related]
17. [Borderline personality disorder is easy to treat: are we ready to accept this good news?].
Venturini A; Andreoli A; Frambati L; Lorillard S; Burnand Y; Ohlendorf P
Rev Med Suisse; 2011 Feb; 7(282):390-4. PubMed ID: 21416866
[TBL] [Abstract][Full Text] [Related]
18. The comorbidity of borderline personality disorder and other DSM-III-R axis II personality disorders.
Nurnberg HG; Raskin M; Levine PE; Pollack S; Siegel O; Prince R
Am J Psychiatry; 1991 Oct; 148(10):1371-7. PubMed ID: 1897619
[TBL] [Abstract][Full Text] [Related]
19. [Comorbidity in patients with narcissistic personality disorder in comparison to patients with borderline personality disorder].
Ritter K; Roepke S; Merkl A; Heuser I; Fydrich T; Lammers CH
Psychother Psychosom Med Psychol; 2010 Jan; 60(1):14-24. PubMed ID: 19235677
[TBL] [Abstract][Full Text] [Related]
20. Predictors of 2-year outcome for patients with borderline personality disorder.
Gunderson JG; Daversa MT; Grilo CM; McGlashan TH; Zanarini MC; Shea MT; Skodol AE; Yen S; Sanislow CA; Bender DS; Dyck IR; Morey LC; Stout RL
Am J Psychiatry; 2006 May; 163(5):822-6. PubMed ID: 16648322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
